ESR1 and breast cancer: Seventy percent (70%) of tumors in obese-OVX group expressed high ERα levels as compared to 30% of mammary tumors from non-obese-OVX rats, similar to breast tumors seen in obese postmenopausal women with a high portion of tumors classified as receptor-positive.